Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local vs Systemic Methotrexate for Uterine Ectopic Pregnancy
NCT06554470Recruiting
- Sponsor
- Tanta University
- Start
- Aug 2024
- Primary completion
- Jul 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of methotrexate in Ectopic pregnancy (EP) (2 arms), sponsored by Tanta University. Primary endpoint: Time for serum beta-human chorionic gonadotropin remission at 3 months. Started Aug 2024; status: recruiting.
02
Drugs
methotrexate
03
Conditions
Ectopic pregnancy (EP)
Beyond the preview
Go deeper on NCT06554470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06554470.